Overview

Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of gefitinib versus pemetrexed as second-line chemotherapy for patients with previous treated non-small cell lung cancer
Phase:
Phase 2
Details
Lead Sponsor:
Gachon University Gil Medical Center
Treatments:
Gefitinib
Pemetrexed